Triptorelin Side Effects: Safety Signals and Warnings
Triptorelin safety concerns are compound-specific. The main listed side effects are Hot flashes, Initial tumor flare (prostate cancer), and Decreased libido and erectile dysfunction. The main warning signals are Initial testosterone flare can worsen prostate cancer symptoms - consider anti-androgen cover for first 2-4 weeks, Long-term use causes significant bone loss - monitor BMD and consider add-back therapy, and Cardiovascular risk may be increased with androgen deprivation therapy.
Direct Answer
Triptorelin (Trelstar) is FDA-approved for prostate cancer androgen deprivation and gender-affirming hormone therapy, with multiple Phase 3 RCTs supporting both indications. As a GnRH agonist, it produces reliable castrate-level testosterone suppression with a well-characterized adverse effect profile. For research into GnRH agonist pharmacology or testosterone suppression, it is a validated reference compound.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Sexual Health
- Best for
- Prostate cancer androgen deprivation, gender-affirming hormone therapy, GnRH agonist pharmacology
Reported Side Effects
- Hot flashes
- Initial tumor flare (prostate cancer)
- Decreased libido and erectile dysfunction
- Bone mineral density loss with prolonged use
- Injection site reactions
- Mood changes and depression
- Fatigue
Warnings
- Initial testosterone flare can worsen prostate cancer symptoms - consider anti-androgen cover for first 2-4 weeks
- Long-term use causes significant bone loss - monitor BMD and consider add-back therapy
- Cardiovascular risk may be increased with androgen deprivation therapy
- Hyperglycemia and diabetes risk elevated in prostate cancer patients on ADT
Known or Plausible Interactions
- Anti-androgens (used for flare protection - bicalutamide, flutamide)
- Drugs that prolong QT interval (additive risk with hypogonadism-related QT changes)
- Hypoglycemic agents (may need dose adjustment due to metabolic effects)
Regulatory Context
FDA-approved prescription medication (Trelstar). Available by prescription only. Not a controlled substance.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Prostate Cancer Control (Level A), Endometriosis Symptom Relief (Level A), and Central Precocious Puberty Arrest (Level A) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "Triptorelin Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/triptorelin-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.